Musinguzi Benson, Obuku Ekwaro A, Mwesigwa Alex, Migisha Richard, Kinengyere Alison Annet, Ndagire Regina, Baguma Andrew, Okek Erick Jacob, Olum Ronald, Itabangi Herbert, Mboowa Gerald, Sande Obondo James, Achan Beatrice
Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Department of Medical Laboratory Science, Faculty of Health Sciences, Muni University, Arua, Uganda.
Trop Med Health. 2024 Nov 27;52(1):88. doi: 10.1186/s41182-024-00649-6.
The introduction of antiretroviral therapy (ART) and the implementation of the human immunodeficiency virus (HIV) universal test and treat (UTT) policy have led to a decline in the incidence of opportunistic infections. However, oropharyngeal and oral candidiasis remain prevalent and continue to pose challenges among people living with human immunodeficiency virus (PLHIV) in Africa, indicating the need for a better understanding of the distribution of Candida species responsible for these infections. This systematic review and meta-analysis aimed to determine the distribution of Candida species isolated from PLHIV with oropharyngeal and oral candidiasis in Africa in the era of UTT policy.
The review followed the preferred reporting items for systematic review and meta-analysis (PRISMA) guidelines. A comprehensive search was conducted to identify eligible studies to be included in the meta-analysis and analysed using a random effects model in STATA version 17. The risk of bias was assessed using the Joanna Briggs Institute quality assessment tool.
Fourteen studies with 4281 participants were included in the review. Overall, 2095 Candida isolates were reported, 78.7% (1650/2095) of which were C. albicans, 19.6% (410/2095), non-albicans Candida (NAC), and 1.7% (35/2095) could not be identified to the Candida specific species level. The most prevalent NAC species were C. glabrata (26.3%), followed by C. tropicalis (24.9%), C. krusei (15.6%), C. parapsilosis (11%), and C. dubliniensis (6.3%). The pooled prevalence of oropharyngeal and oral candidiasis was 48% (95% CI 34-62%). The prevalence of oropharyngeal candidiasis was higher in the pre-UTT era, at 56% (95% CI 40-72%, p < 0.001), than in the post-UTT era, at 34% (95% CI 10-67%, p < 0.001). The risk of bias assessment revealed that 71.4% (10/14) of the included studies had a low risk of bias and that 28.6% (4/14) had a moderate risk of bias.
While C. albicans remain, the predominant species causing oropharyngeal and oral candidiasis among PLHIV in Africa, NAC species also contribute significantly to the infection burden. Despite ART and UTT policies, oropharyngeal candidiasis remains prevalent, emphasizing the need for targeted interventions.
抗逆转录病毒疗法(ART)的引入以及人类免疫缺陷病毒(HIV)普遍检测与治疗(UTT)政策的实施,已导致机会性感染的发病率下降。然而,口咽念珠菌病和口腔念珠菌病仍然普遍存在,并且在非洲的人类免疫缺陷病毒感染者(PLHIV)中继续构成挑战,这表明需要更好地了解导致这些感染的念珠菌种类的分布情况。本系统评价和荟萃分析旨在确定在UTT政策时代,从非洲患有口咽念珠菌病和口腔念珠菌病的PLHIV中分离出的念珠菌种类的分布。
该评价遵循系统评价和荟萃分析的首选报告项目(PRISMA)指南。进行了全面检索,以识别纳入荟萃分析的合格研究,并使用STATA 17版中的随机效应模型进行分析。使用乔安娜·布里格斯研究所质量评估工具评估偏倚风险。
该评价纳入了14项研究,共4281名参与者。总体而言,报告了2095株念珠菌分离株,其中78.7%(1650/2095)为白色念珠菌,19.6%(410/2095)为非白色念珠菌(NAC),1.7%(35/2095)无法鉴定到念珠菌特定种类水平。最常见的NAC种类是光滑念珠菌(26.3%),其次是热带念珠菌(2,4.9%)、克柔念珠菌(15.6%)、近平滑念珠菌(11%)和都柏林念珠菌(6.,3%)。口咽念珠菌病和口腔念珠菌病的合并患病率为48%(95%CI 34 - 62%)。口咽念珠菌病在UTT政策实施前的患病率较高,为56%(95%CI 40 - 72%,p < 0.001),高于UTT政策实施后的患病率34%(95%CI 10 - 67%,p < 0.001)。偏倚风险评估显示,纳入研究的71.4%(10/14)偏倚风险较低,28.6%(4/14)偏倚风险中等。
虽然白色念珠菌仍然是非洲PLHIV中导致口咽念珠菌病和口腔念珠菌病的主要菌种,但NAC菌种也对感染负担有显著贡献。尽管有ART和UTT政策,口咽念珠菌病仍然普遍存在,强调了有针对性干预措施的必要性。